SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
11884491
Source:
http://linkedlifedata.com/resource/pubmed/id/11884491
Search
Subject
(
57
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0006142
,
umls-concept:C0011923
,
umls-concept:C0031268
,
umls-concept:C0032743
,
umls-concept:C0439858
,
umls-concept:C1274040
,
umls-concept:C1516213
,
umls-concept:C1522326
pubmed:issue
3
pubmed:dateCreated
2002-3-8
pubmed:abstractText
This study was conducted to determine the ability of (18)F-FDG PET and conventional imaging (CI) to predict the outcomes in breast cancer patients who have previously undergone primary treatment.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0217410
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Fluorodeoxyglucose F18
,
http://linkedlifedata.com/resource/pubmed/chemical/Radiopharmaceuticals
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0161-5505
pubmed:author
pubmed-author:CzerninJohannesJ
,
pubmed-author:FilmontJean EmmanuelJE
,
pubmed-author:MetaJoubinJ
,
pubmed-author:PhelpsMichael EME
,
pubmed-author:RaoJyotsnaJ
,
pubmed-author:SilvermanDaniel HDH
,
pubmed-author:ValkPeter EPE
,
pubmed-author:VranjesevicDuskaD
pubmed:issnType
Print
pubmed:volume
43
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
325-9
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:11884491-Adult
,
pubmed-meshheading:11884491-Aged
,
pubmed-meshheading:11884491-Aged, 80 and over
,
pubmed-meshheading:11884491-Breast Neoplasms
,
pubmed-meshheading:11884491-Disease-Free Survival
,
pubmed-meshheading:11884491-Female
,
pubmed-meshheading:11884491-Fluorodeoxyglucose F18
,
pubmed-meshheading:11884491-Humans
,
pubmed-meshheading:11884491-Lymph Nodes
,
pubmed-meshheading:11884491-Lymphatic Metastasis
,
pubmed-meshheading:11884491-Magnetic Resonance Imaging
,
pubmed-meshheading:11884491-Middle Aged
,
pubmed-meshheading:11884491-Predictive Value of Tests
,
pubmed-meshheading:11884491-Prognosis
,
pubmed-meshheading:11884491-Radiopharmaceuticals
,
pubmed-meshheading:11884491-Sensitivity and Specificity
,
pubmed-meshheading:11884491-Tomography, Emission-Computed
,
pubmed-meshheading:11884491-Tomography, X-Ray Computed
,
pubmed-meshheading:11884491-Ultrasonography, Mammary
pubmed:year
2002
pubmed:articleTitle
Whole-body (18)F-FDG PET and conventional imaging for predicting outcome in previously treated breast cancer patients.
pubmed:affiliation
Department of Nuclear Medicine, UCLA School of Medicine, Los Angeles, California 90095-6942, USA.
pubmed:publicationType
Journal Article